Home Nucleus Healthcare U.S. Antibody Drug Conjugates (ADC) Market to 2032

U.S. Antibody Drug Conjugates (ADC) Market to 2032

Overview

The U.S. Antibody Drug Conjugates (ADC) Market is expected to reach a 12.11 USD Billion by 2032 and is projected to grow at a CAGR of 17.50% from 2025 to 2032.

Revenue, 2024 (USD Billion)
3.92
Forecast, 2032 (USD Billion)
12.11
CAGR, 2024 - 2032
17.50%
Report Coverage
U.S.

U.S. Antibody Drug Conjugates (ADC) Market 2018-2032 USD Billion

U.S. Antibody Drug Conjugates (ADC) Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 3.92 USD Billion
  • Projected Market Size (2032): 12.11 USD Billion
  • CAGR (2025-2032): 17.50%

Key Findings of U.S. Antibody Drug Conjugates (ADC) Market

  • The U.S. Antibody Drug Conjugates (ADC) Market was valued at 3.92 USD Billion in 2024.
  • The U.S. Antibody Drug Conjugates (ADC) Market is likely to grow at a CAGR of 17.50% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Cleavable Linkers in Linkers Component Segment accounted for the largest share of the market with a revenue of 3.09 USD Billion
  • The fastest growing segment Enhertu in Product Segment grew Fastest with a CAGR of 18.87% during the forecast period from 2024 to 2032.

U.S. Antibody Drug Conjugates (ADC) Market Scope

U.S. Antibody Drug Conjugates (ADC) Market Segmentation & Scope
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tenders
End User
  • Home Healthcare
  • Others
  • Ambulatory Centers
  • Clinics
  • Specialty Center
  • Hospitals
Cytotoxic Payloads or Warheads Component
  • Microtubule Disrupting Agents
  • DNA Damaging Agents
Linkers Component
  • Non Cleavable Linkers
  • Cleavable Linkers
Antibody Component
  • First Generation ADCs
  • Fourth Generation ADCs
  • Second Generation ADCs
  • Third Generation ADCs
Linker Technology
  • Disulfide Linkers
  • Hydrazone Linkers
  • Thioether Linkers
  • Peptide Linkers
Indication
  • Others
  • Genitourinary Cancer
  • Gastrointestinal Cancer
  • Gynecological Cancer
  • Lung Cancer
  • Blood Cancer (Leukemia, Lymphoma)
  • Breast Cancer
Conjugation Technology
  • Chemical Conjugation
  • Site-Specific Conjugation
Antigen Component
  • Tissue Factors
  • CD33
  • CD19
  • Others
  • CD22
  • Nectin 4
  • CD30
  • CD79B
  • Trop-2
  • HER2 Receptor
Product
  • Tivdak
  • Mylotarg
  • Zylonta
  • Elahere
  • Others
  • Besponsa
  • Padcev
  • Adcetris
  • Polivy
  • Trodelvy
  • Kadcyla
  • Enhertu

U.S. Antibody Drug Conjugates (ADC) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2023
Unit Revenue in USD Billion
Market Value in 2024 3.92 USD Billion
Market Value in 2032 12.11 USD Billion
CAGR (2025-2032) 17.50%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,End User,Cytotoxic Payloads or Warheads Component,Linkers Component,Antibody Component,Linker Technology,Indication,Conjugation Technology,Antigen Component,Product

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 3.92 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 3,915.63 USD Million in 2024.

Segments and Scope

  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By Distribution Channel
    • Direct Tenders is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 2.56 USD Billion in the year 2024.
    • Retail Sales is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 17.54 % in forecast period 2025-2032.
  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By End User
    • Hospitals is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 2.30 USD Billion in the year 2024.
    • Ambulatory Centers is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 17.04 % in forecast period 2025-2032.
  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By Cytotoxic Payloads or Warheads Component
    • DNA Damaging Agents is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 2.42 USD Billion in the year 2024.
    • DNA Damaging Agents is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 17.60 % in forecast period 2025-2032.
  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By Linkers Component
    • Cleavable Linkers is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 3.09 USD Billion in the year 2024.
    • Cleavable Linkers is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 17.55 % in forecast period 2025-2032.
  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By Antibody Component
    • Third Generation ADCs is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 2.16 USD Billion in the year 2024.
    • Third Generation ADCs is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 17.70 % in forecast period 2025-2032.
  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By Linker Technology
    • Peptide Linkers is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 2.36 USD Billion in the year 2024.
    • Peptide Linkers is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 17.61 % in forecast period 2025-2032.
  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By Indication
    • Breast Cancer is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 1.61 USD Billion in the year 2024.
    • Breast Cancer is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 18.30 % in forecast period 2025-2032.
  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By Conjugation Technology
    • Site-Specific Conjugation is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 2.16 USD Billion in the year 2024.
    • Site-Specific Conjugation is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 18.07 % in forecast period 2025-2032.
  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By Antigen Component
    • HER2 Receptor is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 2.30 USD Billion in the year 2024.
    • HER2 Receptor is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 17.96 % in forecast period 2025-2032.
  • U.S. Antibody Drug Conjugates (ADC) Market to 2032, By Product
    • Enhertu is the largest segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 1.33 USD Billion in the year 2024.
    • Enhertu is the Fastest growing segment in U.S. Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 18.87 % in forecast period 2025-2032.

U.S. Antibody Drug Conjugates (ADC) Market Company Share Analysis

 
Company Name Company Share Analysis
Takeda Pharmaceutical Company Limited
Astellas Pharma Inc.
Gilead Sciences, Inc.
DAIICHI SANKYO COMPANY, LIMITED
F. Hoffmann-La Roche Ltd.
U.S. Antibody Drug Conjugates (ADC) Market Company Share Analysis

U.S. Antibody Drug Conjugates (ADC) Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Antibody Drug Conjugates (ADC) Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Antibody Drug Conjugates (ADC) Market Company Profiling

U.S. Antibody Drug Conjugates (ADC) Market Company Profiling

Industry Related Reports

Asia-Pacific Discharge Inks Market for Textile Industry Market
Europe Discharge Inks Market for Textile Industry Market
North America Discharge Inks Market for Textile Industry Market
Middle East & Africa Discharge Inks Market for Textile Industry Market
South America Discharge Inks Market for Textile Industry Market
United Arab Emirates Discharge Inks Market for Textile Industry Market
Argentina Discharge Inks Market for Textile Industry Market
Australia Discharge Inks Market for Textile Industry Market
Belgium Discharge Inks Market for Textile Industry Market
Brazil Discharge Inks Market for Textile Industry Market
Frequently Asked Questions
The U.S. Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation Distribution Channel,End User,Cytotoxic Payloads or Warheads Component,Linkers Component,Antibody Component,Linker Technology,Indication,Conjugation Technology,Antigen Component,Product.
U.S. Antibody Drug Conjugates (ADC) Market was valued at USD 3.92(Revenue in USD Billion) in 2023.
U.S. Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 17.50% during the forecast period of 2024 to 2032.
The Cleavable Linkers segment is expected to dominate the U.S. Antibody Drug Conjugates (ADC) Market, holding a largest market share of 3.09 USD Billion in 2024

Coming Soon....

U.S. Antibody Drug Conjugates (ADC) Market Scope

U.S. Antibody Drug Conjugates (ADC) Market Segmentation & Scope
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tenders
End User
  • Home Healthcare
  • Others
  • Ambulatory Centers
  • Clinics
  • Specialty Center
  • Hospitals
Cytotoxic Payloads or Warheads Component
  • Microtubule Disrupting Agents
  • DNA Damaging Agents
Linkers Component
  • Non Cleavable Linkers
  • Cleavable Linkers
Antibody Component
  • First Generation ADCs
  • Fourth Generation ADCs
  • Second Generation ADCs
  • Third Generation ADCs
Linker Technology
  • Disulfide Linkers
  • Hydrazone Linkers
  • Thioether Linkers
  • Peptide Linkers
Indication
  • Others
  • Genitourinary Cancer
  • Gastrointestinal Cancer
  • Gynecological Cancer
  • Lung Cancer
  • Blood Cancer (Leukemia, Lymphoma)
  • Breast Cancer
Conjugation Technology
  • Chemical Conjugation
  • Site-Specific Conjugation
Antigen Component
  • Tissue Factors
  • CD33
  • CD19
  • Others
  • CD22
  • Nectin 4
  • CD30
  • CD79B
  • Trop-2
  • HER2 Receptor
Product
  • Tivdak
  • Mylotarg
  • Zylonta
  • Elahere
  • Others
  • Besponsa
  • Padcev
  • Adcetris
  • Polivy
  • Trodelvy
  • Kadcyla
  • Enhertu
Frequently Asked Questions
The U.S. Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation Distribution Channel,End User,Cytotoxic Payloads or Warheads Component,Linkers Component,Antibody Component,Linker Technology,Indication,Conjugation Technology,Antigen Component,Product.
U.S. Antibody Drug Conjugates (ADC) Market was valued at USD 3.92(Revenue in USD Billion) in 2023.
U.S. Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 17.50% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Antibody Drug Conjugates (ADC) Market for final year is USD 12.11 (USD Billion).

U.S. Antibody Drug Conjugates (ADC) Market Company Profiling

U.S. Antibody Drug Conjugates (ADC) Market Company Profiling
Frequently Asked Questions
The U.S. Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation Distribution Channel,End User,Cytotoxic Payloads or Warheads Component,Linkers Component,Antibody Component,Linker Technology,Indication,Conjugation Technology,Antigen Component,Product.
U.S. Antibody Drug Conjugates (ADC) Market was valued at USD 3.92(Revenue in USD Billion) in 2023.
U.S. Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 17.50% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Antibody Drug Conjugates (ADC) Market for final year is USD 12.11 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.